INSMED Inc
INSM- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001104506
In the last 90 days, INSMED Inc insiders filed 0 open-market purchases and 2 sales; 672 institutions reported holding it in 13F filings for Q2 2026, worth $23.9B in total; superinvestors Maverick Capital and Duquesne Family Office hold it.
Key figures
- Market capClose on Nov 16, 2026
- $27.0B
- Insider buysOpen market, last 90 days
- 0
- Insider sellsLast 90 days, $3.74M in total
- 2
- 13F holdersQ2 2026, −4 vs. previous quarter
- 672
- 13F valueReported value at the end of Q2 2026
- $23.9B
- Superinvestors holdingAt the end of Q2 2026
- 2
Price chart
Financials
See financial statementsFrom SEC filings, in USD.
- Revenue, FY2025
- $606.4M
- +66.7% year over year
- Net income, FY2025
- -$1.28B
- No comparable prior period
- Free cash flow, FY2025
- -$967.6M
- No comparable prior period
- Revenue, Q3 FY2026
- $524.4M
- +268.4% year over year
Revenue flow, FY2025
Green is profit; orange is costs, expenses and taxes. Percentages are shares of revenue.
Net loss for FY2025: $1.28B (210.5% of revenue).
Short interest
See short dataFrom FINRA, settlement date Oct 30, 2026.
- Short interest
- 14.1M
- Shares sold short
- Change
- +602.8K
- +4.5% vs. previous
- Days to cover
- 3.56
- At average daily volume
Superinvestors holding INSM, Q2 2026
Go to the superinvestors tab2 superinvestors report holding INSMED Inc on Form 13F. Percentages are the stock's share of each portfolio.
Duquesne Family Office
Stanley Druckenmiller
3.5%
INSMED Inc's share of the portfolio
- Shares
- 1,424,690
- Value
- $151.9M
Latest insider trades
See all insider tradesOpen-market purchases and sales by INSMED Inc insiders from Form 4, newest first.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Sep 11, 2026 (view filing)4:04 PM ET | Sep 9 | 2 days | Brennan David RDirector | SSale | −25.0K | $124.00 | −$3.10M | −38.9%39.2K after | |
| Aug 19, 2026 (view filing)4:10 PM ET | Aug 17 | 2 days | Sharoky Melvin MDDirector | SSale | −5.00K | $127.53 | −$637.6K | −100.0%0 after | |
| Aug 12, 2026 (view filing)5:04 PM ET | Aug 10 | 2 days | Adsett RogerChief Operating Officer | SSale | −239.8K | $133.27 | −$32.0M | −70.8%98.7K after | |
| Aug 7, 2026 (view filing)4:39 PM ET | Aug 6 | 1 day | Flammer Martina M.D.Chief Medical Officer | SSale | −27.2K | $128.61 | −$3.49M | −31.0%60.5K after | 2 lots10b5-1 |
| Jul 24, 2026 (view filing)5:02 PM ET | Jul 23 | 1 day | Lewis WilliamChair and CEO | SSale | −10.7K | $106.06 | −$1.13M | −4.0%259.1K after | 2 lots10b5-1 |
| Jul 10, 2026 (view filing)4:02 PM ET | Jul 9 | 1 day | Lewis WilliamChair and CEO | SSale | −10.7K | $117.40 | −$1.26M | −4.0%259.1K after | 3 lots10b5-1 |
| Jul 8, 2026 (view filing)4:03 PM ET | Jul 6 | 2 days | Flammer Martina M.D.Chief Medical Officer | SSale | −12.3K | $109.98 | −$1.35M | −16.9%60.5K after | 2 lots10b5-1 |
| Jun 26, 2026 (view filing) | Jun 25 | 1 day | Lewis WilliamChair and CEO | SSale | −21.4K | $103.32 | −$2.21M | −7.6%258.9K after | 5 lots10b5-1 |
| Jun 24, 2026 (view filing) | Jun 22 | 2 days | Smith Michael AlexanderChief Legal Officer | SSale | −1.81K | $95.82 | −$173.1K | −4.6%37.6K after | 10b5-1 |
| Jun 10, 2026 (view filing) | Jun 8 | 2 days | Lewis WilliamChair and CEO | SSale | −6.51K | $94.03 | −$612.6K | −2.5%258.9K after | 10b5-1 |
Top 10 13F holders, Q2 2026
See all 672 holdersThe largest institutional positions in INSMED Inc at the end of Q2 2026; share changes are against Q1 2026.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| FMR LLC | 16,143,583 | $1.72B | 0.07% | +2,983,416+22.7% | Added |
| BlackRock, Inc. | 15,807,984 | $1.69B | 0.03% | −870,162−5.2% | Reduced |
| Vanguard Portfolio Management LLC | 10,407,962 | $1.11B | 0.05% | +36,160+0.3% | Added |
| JPMorgan Chase & Co | 10,428,170 | $1.09B | 0.06% | −13,722,329−56.8% | Reduced |
| Vanguard Capital Management LLC | 9,790,865 | $1.04B | 0.02% | +148,734+1.5% | Added |
| Baker Bros. Advisors LP | 8,796,111 | $937.8M | 4.70% | +1,375,000+18.5% | Added |
| Capital International Investors | 8,238,124 | $878.3M | 0.18% | +2,642,930+47.2% | Added |
| Darwin Global Management, Ltd. | 6,431,163 | $673.6M | 17.91% | −10,374,021−61.7% | Reduced |
| Ameriprise Financial Inc | 6,179,571 | $658.9M | 0.13% | +3,121,853+102.1% | Added |
| Orbis Allan Gray Ltd | 6,076,487 | $647.9M | 2.23% | +4,203,663+224.5% | Added |
Holders of 5% or more of INSM
See all 3 holders and filingsHolders whose latest Schedule 13D or 13G filing reports 5% or more of INSMED Inc.
| Holder | Latest form | Stake | Change | First filed | Latest filing | Filing |
|---|---|---|---|---|---|---|
| FMR LLC | 13G/A | 7.40%16.1M shares | +1.30 ppfrom 6.10% | Feb 8, 20215 filings | Aug 6, 2026 | SEC |
| BlackRock, Inc. | 13G/A | 6.60%14.1M shares | +1.50 ppfrom 5.10% | Jul 17, 20252 filings | Jan 21, 2026 | SEC |
| Vanguard Capital Management LLC | 13G | 5.34%11.5M shares | New | Apr 30, 20261 filing | Apr 30, 2026 | SEC |
Politician trades
All politician trades in INSM2 members of Congress reported 10 trades in INSMED Inc since 2020. Newest filings:
| Filed | Politician | Type | Amount |
|---|---|---|---|
| Jul 7, 2026 | Josh Gottheimer House · NJ | Sell (partial) | $1K-$15K |
| Nov 18, 2025 | Gilbert Ray Cisneros, Jr. House · CA | Sell | $1K-$15K |
| Oct 10, 2025 | Gilbert Ray Cisneros, Jr. House · CA | Sell (partial) | $1K-$15K |
| Sep 12, 2025 | Gilbert Ray Cisneros, Jr. House · CA | Sell (partial) | $1K-$15K |
| Aug 14, 2025 | Gilbert Ray Cisneros, Jr. House · CA | Sell (partial) | $1K-$15K |

House · NJ · Jul 7, 2026
Sell (partial)$1K-$15K

House · CA · Nov 18, 2025
Sell$1K-$15K

House · CA · Oct 10, 2025
Sell (partial)$1K-$15K

House · CA · Sep 12, 2025
Sell (partial)$1K-$15K

House · CA · Aug 14, 2025
Sell (partial)$1K-$15K